Will the BEAUTIFUL Study results change our views on heart rate control?

The article describes the results of a randomized, double-blind, placebo-controlled, parallel-group BEAUTIFUL trial. The position of an If inhibitor ivabradine in the current algorithm of antianginal therapy is analyzed

Bibliographic Details
Main Author: Yu. M. Lopatin
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1731